熱門資訊> 正文
硕腾公司有条件批准Dectomax-CA 1用于牛寄生虫感染
2025-10-01 05:34
- The US FDA has given conditional approval to Dectomax-CA1 (doramectin), an injection to treat New World screwworm myiasis in cattle.
- The infection is caused by larvae of the new world screwworm fly feeding on the flesh of animals.
- Although New World screwworm was eradicated in the US in 1966, Zoetis said that there is a constant risk of re-introduction.
More on Zoetis
- Zoetis: Pet Pain Spells Potential Further Gains, But Valuation Suggests A Hold
- Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Zoetis: A Solid Dividend Growth Investment For The Long Haul
- Zoetis prices $1.85B senior notes
- Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
